France will press its G7 partners this month to launch an “irreversible” process to control the prices of new medicines, part of a global drive to make life-saving drugs more affordable.
Startup Homology Medicines Launches With $43 Million Series A, To Be Led By Three Former Shire Execs May 2, 2016By Mark Terry, BioSpace.com Breaking News Staff Lexington, Mass.-based Homology Medicines launched today with a $43.5 million Series A preferred stock financing. The round was co-led by 5AM Ventures and ARCH Venture Partners. They […]
May 2, 2016By Mark Terry, BioSpace.com Breaking News Staff EMD Serono announced today that it was building a $12 million expansion of its research-and-development facility in Billerica, Mass. EMD Serono is the U.S. subsidiary of Darmstadt, Germany-based Merck KgaA (MRK). The expansion will add 30,000 square feet to the existing space at the Sagamore […]
May 2, 2016 By Alex Keown, BioSpace.com Breaking News Staff CAMBRIDGE, Mass. – Shares of Bind Therapeutics (BIND) are down more than 64 percent this morning after BIND filed Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware, the company announced this morning. Shares of BIND are trading at 51 cents […]